Session Information
Session Type: Abstract Submissions (ACR)
Background/Purpose: Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease with an estimated prevalence of 40:100,000 cases in European populations. SLE has a strong genetic risk component (sibling relative risk ~30). Positional candidate studies have identified the association of HLADRB1, STAT4 and IRF5 loci with SLE risk. However, Genome-Wide Association Studies (GWAS) have allowed to expand the number of SLE risk loci to more than 20. In order to identify additional risk loci we have performed a GWAS in a Southern European population.
Methods: 510 SLE cases and 1,540 controls of Spanish origin were genotyped for more than 550,000 SNPs using Illumina Quad-610 platform. Only SNPs having >95% call rate and individuals having 95% of SNPs genotyped were included. Principal Component Analysis was used to identify the main axis of variation and discard any population outlier. After QC-filtering 489 SLE cases and 1490 Controls were included to test for association. In order to evaluate the association of all previously known SLE-risk loci all GWASs published from 2,008 to 2,012 where evaluated. Loci associated at a nominal P-value < 5e-5 were included. Within each SLE risk locus (n=43), the SNP having the highest statistical evidence was selected. For those SNPs not directly genotyped (n=3) genotype was imputed using MACH v1.0 software.
Results: From the 24 loci previously showing Genome-Wide level of association (P<5e-8) with SLE risk, loci HLA-DRB1, ITGAM, STAT4 and MSH5 were also replicated at Genome-Wide level. Four additional loci were also replicated at nominal (P<0.05) level of significance. From the remaining 19 loci still requiring additional evidence (5e-8 < P < 5 e-5) we were able to nominally replicate three loci. 20 SNPs within genomic regions previously not associated with SLE were also identified (P<5e-5).
Conclusion: The present study has validated previous SLE risk loci in an independent population and gives additional support to loci with suggestive association. The association of the new candidate risk loci for SLE identified in this GWAS is currently being tested for validation.
Disclosure:
A. Fernandez-Nebro,
None;
P. E. Carreira,
None;
R. Blanco,
None;
V. M. Martinez-Taboada,
None;
L. Carreño,
None;
A. Olive,
None;
J. L. Andreu,
None;
M. A. Aguirre,
None;
P. Vela,
None;
J. J. Pérez Venegas,
None;
J. L. Marenco,
None;
J. M. Nolla,
None;
A. Zea,
None;
J. M. Pego-Reigosa,
None;
M. Freire González,
None;
G. Ávila,
None;
M. A. López-Lasanta,
None;
R. Tortosa,
None;
A. Julià,
None;
S. Marsal,
None.
« Back to 2012 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/genomewide-association-study-in-systemic-lupus-erythematosus-known-loci/